CN104940719A - 一种缓解尿毒症的健脾补肾丸剂及其制备方法 - Google Patents
一种缓解尿毒症的健脾补肾丸剂及其制备方法 Download PDFInfo
- Publication number
- CN104940719A CN104940719A CN201510317179.8A CN201510317179A CN104940719A CN 104940719 A CN104940719 A CN 104940719A CN 201510317179 A CN201510317179 A CN 201510317179A CN 104940719 A CN104940719 A CN 104940719A
- Authority
- CN
- China
- Prior art keywords
- parts
- semen
- radix
- minute
- minutes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003734 kidney Anatomy 0.000 title claims abstract description 83
- 210000000952 spleen Anatomy 0.000 title claims abstract description 74
- 239000006187 pill Substances 0.000 title claims abstract description 64
- 208000037157 Azotemia Diseases 0.000 title claims abstract description 14
- 208000009852 uremia Diseases 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims description 30
- 210000000582 semen Anatomy 0.000 claims abstract description 89
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 22
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 21
- 235000008434 ginseng Nutrition 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 239000003814 drug Substances 0.000 claims description 57
- 238000005728 strengthening Methods 0.000 claims description 57
- 241000222640 Polyporus Species 0.000 claims description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 45
- 229940079593 drug Drugs 0.000 claims description 28
- 239000009636 Huang Qi Substances 0.000 claims description 26
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 24
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 23
- 238000003756 stirring Methods 0.000 claims description 22
- 235000015099 wheat brans Nutrition 0.000 claims description 21
- 238000001035 drying Methods 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 14
- 235000013305 food Nutrition 0.000 claims description 14
- 229910052742 iron Inorganic materials 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 238000002791 soaking Methods 0.000 claims description 11
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 7
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 7
- 238000012545 processing Methods 0.000 claims description 7
- 238000009423 ventilation Methods 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 4
- 241000208340 Araliaceae Species 0.000 claims 4
- 230000000694 effects Effects 0.000 abstract description 19
- 208000024891 symptom Diseases 0.000 abstract description 19
- 230000006870 function Effects 0.000 abstract description 14
- 230000001939 inductive effect Effects 0.000 abstract description 3
- 238000011084 recovery Methods 0.000 abstract description 3
- 240000002853 Nelumbo nucifera Species 0.000 abstract description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract description 2
- 230000004064 dysfunction Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 241000231176 Boschniakia rossica Species 0.000 abstract 1
- 244000146462 Centella asiatica Species 0.000 abstract 1
- 235000004032 Centella asiatica Nutrition 0.000 abstract 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 241000759833 Cornus officinalis Species 0.000 abstract 1
- 241000222684 Grifola Species 0.000 abstract 1
- 241000123069 Ocyurus chrysurus Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000010726 Vigna sinensis Nutrition 0.000 abstract 1
- 244000042314 Vigna unguiculata Species 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 230000003750 conditioning effect Effects 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 239000008280 blood Substances 0.000 description 16
- 230000007812 deficiency Effects 0.000 description 16
- 201000010099 disease Diseases 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 14
- 208000020832 chronic kidney disease Diseases 0.000 description 14
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 14
- 208000004880 Polyuria Diseases 0.000 description 11
- 230000035619 diuresis Effects 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 7
- 206010003549 asthenia Diseases 0.000 description 7
- 210000000988 bone and bone Anatomy 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 7
- 210000000629 knee joint Anatomy 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 239000003792 electrolyte Substances 0.000 description 6
- 229930182470 glycoside Natural products 0.000 description 6
- 201000001881 impotence Diseases 0.000 description 6
- 206010025482 malaise Diseases 0.000 description 6
- 230000027939 micturition Effects 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 210000003127 knee Anatomy 0.000 description 5
- 208000001889 Acid-Base Imbalance Diseases 0.000 description 4
- 208000010228 Erectile Dysfunction Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 235000021152 breakfast Nutrition 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 150000002338 glycosides Chemical class 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 208000026372 Congenital cystic kidney disease Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 208000007443 Neurasthenia Diseases 0.000 description 3
- 208000001647 Renal Insufficiency Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000001142 anti-diarrhea Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- -1 coumarin, flavone Chemical class 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 201000006370 kidney failure Diseases 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000005787 Cistanche Species 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- WRACWYWAPQQRKC-UHFFFAOYSA-N Madasiatic acid Chemical compound C1C(O)C(O)C(C)(C)C2C(O)CC3(C)C4(C)CCC5(C(O)=O)CCC(C)C(C)C5C4=CCC3C21C WRACWYWAPQQRKC-UHFFFAOYSA-N 0.000 description 2
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 2
- 229940022757 asiaticoside Drugs 0.000 description 2
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 2
- 238000013475 authorization Methods 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000018631 connective tissue disease Diseases 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 238000001631 haemodialysis Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000000322 hemodialysis Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 210000004705 lumbosacral region Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 208000030761 polycystic kidney disease Diseases 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 208000024985 Alport syndrome Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- 241000201308 Boschniakia Species 0.000 description 1
- OPRAONAUWNNOOV-UHFFFAOYSA-N Boschniakin Natural products C1=NC=C(C=O)C2=C1C(C)CC2 OPRAONAUWNNOOV-UHFFFAOYSA-N 0.000 description 1
- OPRAONAUWNNOOV-ZETCQYMHSA-N Boschniakine Natural products C1=NC=C(C=O)C2=C1[C@@H](C)CC2 OPRAONAUWNNOOV-ZETCQYMHSA-N 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- OOCCDEMITAIZTP-QPJJXVBHSA-N Cinnamyl alcohol Natural products OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 241000207782 Convolvulaceae Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 206010013647 Drowning Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 208000026019 Fanconi renotubular syndrome Diseases 0.000 description 1
- 201000006328 Fanconi syndrome Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046528 Urinary bladder haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047370 Vesicoureteric reflux Diseases 0.000 description 1
- 241000219977 Vigna Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 1
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000004670 arteriolosclerosis Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 1
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 1
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000003215 hereditary nephritis Diseases 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229930182489 iridoid glycoside Natural products 0.000 description 1
- 150000008145 iridoid glycosides Chemical class 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- PRAUVHZJPXOEIF-AOLYGAPISA-N madecassic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2[C@H](O)C[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C PRAUVHZJPXOEIF-AOLYGAPISA-N 0.000 description 1
- PRAUVHZJPXOEIF-UHFFFAOYSA-N madecassica acid Natural products C1C(O)C(O)C(C)(CO)C2C(O)CC3(C)C4(C)CCC5(C(O)=O)CCC(C)C(C)C5C4=CCC3C21C PRAUVHZJPXOEIF-UHFFFAOYSA-N 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000003818 metabolic dysfunction Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000000885 nephron Anatomy 0.000 description 1
- 201000002648 nephronophthisis Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001662 opsonic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000004793 poor memory Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000037821 progressive disease Diseases 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 201000005966 renal hypoplasia Diseases 0.000 description 1
- 231100001028 renal lesion Toxicity 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 201000008618 vesicoureteral reflux Diseases 0.000 description 1
- 208000031355 vesicoureteral reflux 1 Diseases 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种缓解尿毒症的健脾补肾丸剂,取下述重量配比的主要原料制备而成:积雪草1-5份,刺五加2-6份,藕4-10份,山茱萸3-8份,薏苡仁2-4份,猪苓1-3份,人参6-10份,车前子1-5份,地胆头10-20份,茯苓5-15份,肉桂4-10份,茜草10-20份,豇豆7-18份,菟丝子6-14份,黄芪8-19份,草苁蓉5-7份。该健脾补肾丸剂对尿毒症症状的效果显著,不仅有补肾、利尿的功效,还能够从根源调理尿毒症的内脏功能紊乱,对于久病而致精神萎靡,神情疲乏者有良好的恢复和调理作用。本发明多选用地方常见药材,价格低廉,减轻了患者的经济负担。
Description
技术领域
本发明属中医中药领域,尤其是涉及一种能缓解尿毒症的健脾补肾丸剂及其制备方法。
背景技术
慢性肾功能衰竭(CRF)又称尿毒症,是指各种原因造成的慢性进行性肾实质损害,致使肾脏明显萎缩,不能维持其基本功能,临床出现以代谢产物潴留,水、电解质、酸碱平衡失调,全身各系统受累为主要表现的临床综合征,也称为尿毒症。从原发病起病到肾功能不全的开始,间隔时间可为数年到十余年。慢性肾功能衰竭是肾功能不全的严重阶段。病因:慢性肾功能衰竭的病因以各种原发性及继发性肾小球肾炎占首位,其次为泌尿系统先天畸形(如肾发育不良,先天性多囊肾,膀胱输尿管反流等),遗传性疾病(如遗传性肾炎,肾髓质囊性病,Fanconi综合征等)全身性系统疾病中以肾小动脉硬化,高血压,结缔组织病等多见,近年来,CRF的原发病有所变化,肾间质小管损害引起的CRF也逐渐受到人们的重视,糖尿病肾病,自身免疫性与结缔组织疾病肾损害,引起的CRF也有上升趋势。临床表现:慢性肾功能衰竭影响到各个系统和器官,可引起多种多样的临床表现,但是,在80%的肾单位丧失以前,或当GFP下降到25ml/分钟以前,可以没有任何症状或只有很少的生化改变,在诸如多囊肾等慢性进行性疾病中,即使GFR低于10ml/分钟,也可以没有症状,这是由于残存肾单位巨大的适应作用所致。慢性肾功能衰竭晚期主要引起如下多种临床病变:1.水,电解质,酸碱平衡紊乱:肾脏的基本功能即调节水,电解质,酸碱平衡,肾功能不全时,由于其排泄或代谢功能障碍,必然会引起不同程度的水,电解质,酸碱平衡紊乱,然而,同ARF不一样,CRF在其漫长的病程中由于机体各种代偿机制,这些代谢紊乱有时显得并不十分明显,事实上,在轻中度CRF时,丧失部分功能的肾脏仍然较完全地排出各种外源性摄入和体内产生的物质或废物,当正常的肾功能丧失约70%时,一般只会出现部分水,电解质,酸碱平衡紊乱,只有当肾功能进一步下降,以及摄入或体内产生过多的水,电解质,酸性或碱性物质才会出现明显的临床表现。2.糖,脂肪,蛋白质和氨基酸代谢障碍。3.各系统功能障碍:①消化系统;②心血管系统;③呼吸系统;④神经系统;⑤血液系统;⑥运动系统;⑦皮肤变化;⑧免疫系统;⑨内分泌系统,均发生不同程度的障碍。
在现有治疗慢性肾衰竭的方法中,授权公告号 CN 102688414 B(申请号 201210210548.X)公开了一种治疗尿毒症血液透析并发症的中药健脾补肾丸剂片剂,其特征在于:所述中药健脾补肾丸剂片剂仅由黄芪、人参、山药、薏苡仁、红花、猪苓、瓦松、石斛、龙眼肉、蒲公英、当归、地肤子、昆布、益母草、丹参、商陆、巴戟天、云芝、补骨脂和刺五加作为原料药构成;授权公告号 CN 102716339 B(申请号 201210224055.1)的专利公开了一种配合血液透析治疗尿毒症的中药健脾补肾丸剂,其特征在于,所述中药健脾补肾丸剂中各组分的重量份为:亚乎奴10 - 20 重量份、北沙参20 - 30 重量份、白及10 - 20 重量份、白芍25 - 35 重量份、牡蛎10 - 20 重量份、墨旱莲30 - 40 重量份、白鲜皮10 - 20 重量份、熟地黄20 - 30 重量份、菊花15 - 25 重量份、川芎20 - 30 重量份、车前草10 - 20 重量份、石韦10 - 20 重量份、麦冬30 - 40 重量份、枸杞子25 - 35 重量份、淫羊藿10 - 20 重量份、猪苓60 - 70 重量份、荆芥10 - 20 重量份、芒硝15 - 25 重量份、鸡血藤25 - 35 重量份和茯苓30 - 40 重量份。
由此可见:中医药治疗慢性肾功能衰竭可缓解临床症状,保护残余肾功能,延缓病情发展,推迟必须透析和肾移植的时间,越来越受到国内外医学界的重视。慢性肾功能衰竭属中医学关格、水肿、溺毒、虚劳等范畴,中医学认为该病迁延日久或外邪侵袭,劳倦内伤,导致脏腑功能虚损,湿浊羁留,壅塞三焦,气机升降失常,虽病情危重,证候复杂,但本虚标实是贯穿病程始终的主要病机。本虚以脾肾阳( 气) 虚为主,标实以湿浊、水毒、瘀血为主,治疗应扶正祛邪。
发明内容
针对现有缓解尿毒症的药物不足的现状,本发明的目的之一在于提供一种快速有效的缓解尿毒症的健脾补肾丸剂,具有易操作、疗效显著的特点,并且它采用地方上较为常见的中药材作为原料,成本低廉。
本发明的另一目的就是提供上述健脾补肾丸剂的制备方法。
本发明的上述目的是通过以下技术方案来实现的:
缓解尿毒症的健脾补肾丸剂,取下述重量配比的主要原料制备而成:积雪草1-5份, 刺五加2-6份,藕4-10份,山茱萸3-8份,薏苡仁2-4份,猪苓1-3份,人参6-10份,车前子1-5份,地胆头10-20份,茯苓5-15份,肉桂4-10份,茜草10-20份,豇豆7-18份,菟丝子6-14份,黄芪8-19份,草苁蓉5-7份。
缓解尿毒症的健脾补肾丸剂,优选的方案,取下述重量配比的主要原料制备而成:积雪草2-4份, 刺五加3-5份,藕6-8份,山茱萸5-7份,薏苡仁2.5-3.5份,猪苓1.5-2.5份,人参7-9份,车前子2-4份,地胆头13-18份,茯苓8-13份,肉桂6-8份,茜草13-18份,豇豆10-15份,菟丝子8-12份,黄芪12-17份,草苁蓉5.5-6.5份。
缓解尿毒症的健脾补肾丸剂,更佳优选的方案,取下述重量配比的主要原料制备而成:积雪草3份, 刺五加4份,藕7份,山茱萸6份,薏苡仁3份,猪苓2份,人参8份,车前子3份,地胆头15份,茯苓10份,肉桂7份,茜草15份,豇豆12份,菟丝子10份,黄芪14份,草苁蓉6份。
上述缓解尿毒症健脾补肾丸剂的制备步骤如下:
①将草苁蓉和猪苓洗净,置于阴凉通风处晾干,捣碎后放入瓦罐中,加入黄酒,稍焖1-3小时,得酒草苁蓉和猪苓,将麸皮置于干锅内,将麸皮炒制滑利状态,投入酒草苁蓉和猪苓,反复翻炒3-8分钟,停火,筛去麸皮,将炒制好的草苁蓉和猪苓晾凉研磨成细末过80-120目筛待用;
②将藕去皮,与豇豆一同洗净,切成豆粒大小的块,置于蒸笼上,加热10-20分钟,稍焖10分钟取出,铺设在干净的铁板上小火慢烘5-10分钟,取出晾凉至室温,研磨成细末待用;
③将积雪草、 刺五加、地胆头、人参和茜草洗净,打碎,将热锅烧干,投入处理好的原料药,反复翻炒2-6分钟,晾至室温,研磨成细末待用;
④将山茱萸、薏苡仁、车前子、茯苓、肉桂、菟丝子和黄芪用50-70℃的水浸泡50-70分钟,置于砂锅内加水煎煮20-50分钟,用水量为原料药总重量的2-4倍,过滤得滤液;
⑤将步骤①-③所得细末与步骤④所得滤液混匀,充分搅拌5-10分钟后加入蜂蜜,快速搅拌成稠膏,将稠膏烘10-30分钟,得烘干物,将烘干物按照丸剂的加工制备方法制成圆形,包装即得。
上述健脾补肾丸剂的制备方法,步骤①加入黄酒,稍焖1.5-2.5小时(优选加入黄酒,稍焖2小时)。
上述健脾补肾丸剂的制备方法,步骤①投入酒草苁蓉和猪苓,反复翻炒5-7分钟(优选投入酒草苁蓉和猪苓,反复翻炒6分钟)。
上述健脾补肾丸剂的制备方法,步骤②置于蒸笼上,加热13-18分钟,稍焖10分钟取出,铺设在干净的铁板上小火慢烘6-9分钟(优选置于蒸笼上,加热15分钟,稍焖10分钟取出,铺设在干净的铁板上小火慢烘7分钟)。
上述健脾补肾丸剂的制备方法,步骤③投入处理好的原料药,反复翻炒3-5分钟,晾至室温(优选投入处理好的原料药,反复翻炒4分钟,晾至室温)。
上述健脾补肾丸剂的制备方法,步骤④将山茱萸、薏苡仁、车前子、茯苓、肉桂、菟丝子和黄芪用55-65℃的水浸泡55-65分钟,置于砂锅内加水煎煮30-40分钟,用水量为原料药总重量的2.5-3.5倍(优选将山茱萸、薏苡仁、车前子、茯苓、肉桂、菟丝子和黄芪用60℃的水浸泡60分钟,置于砂锅内加水煎煮35分钟,用水量为原料药总重量的3倍)。
上述健脾补肾丸剂的制备方法,步骤⑤充分搅拌6-9分钟后加入蜂蜜,快速搅拌成稠膏,将稠膏烘15-25分钟(优选充分搅拌8分钟后加入蜂蜜,快速搅拌成稠膏,将稠膏烘20分钟)。
使用方法:为使本发明健脾补肾丸剂达到最佳治疗效果,每日三次,于三餐后半小时服用,每次取1-3片,用温开水送服。
该健脾补肾丸剂对尿毒症症状的效果显著,不仅有补肾、利尿的功效,还能够从根源调理尿毒症的内脏功能紊乱,对于久病而致精神萎靡,神情疲乏者有良好的恢复和调理作用。本发明多选用地方常见药材,价格低廉,减轻了患者的经济负担。
各原料药的药理功效分别为:
积雪草:基原:为双子叶植物伞形科积雪草的干燥全草或带根全草。成分:含多种α-香树脂醇型的三萜成分,其中有积雪草苷、参枯尼苷、异参枯尼苷,羟基积雪草苷,玻热模苷、破热米苷和破热米酸等,以及马达积雪草酸。药性:苦、辛,寒。归肝、脾、肾经。功用主治:清热解毒,利湿消肿。是东方人的长寿药,可益脑提神。研究表明具有滋补、消炎、愈合伤口、利尿通便和镇定作用。对麻风病、溃疡也有疗效,对血液净化及免疫力有激活作用,因其可刺激深层皮肤细胞的更替。它是神经滋补剂,能提高记忆力,减轻精神疲劳;还可降血压,治疗肝病等。
刺五加:1、用于风湿痹痛,腰膝酸痛。本品功能祛风湿,又能补肝肾,强筋骨,可用于风湿痹痛、筋骨拘挛、腰膝酸痛等症,对肝肾不足有风湿者最为适用 2、用于肝肾不足、腰膝酸痛、脚膝痿弱无力、小儿行迟等症本品又能温补肝肾、强筋健骨,可用治肝肾不足所致腰膝酸疼、下肢痿弱以及小儿行迟等症3、用于水肿、小便不利。本品又能利水消肿,治水肿、小便不利,常配合茯苓皮、大腹皮、生姜皮、地骨等药同用。4、黄褐斑:刺五加片每次3片,每日3次,30日为1疗程,一般治疗3-6个疗程可显效,该品能调整脏腑气血功能,缓解血液循环,促进新陈代谢,使皮肤得到足够的气血运行和正常营养,从而达到润五脏、悦颜色之目的。5、辅助治疗心律失常:口服刺五加片每次3片,每日3次,30日为1疗程。刺五加可“补中、益精,强意志”,调养心脾,对于心气虚乏所致该病有良效。6、低血压:每日口服刺五加片3次,每次3片,治疗90天后观察效果,其疗效明显优于服用维生素C,复合维生素B对照组。7、足跟痛:刺五加能“益气补肾、坚筋骨,强腰膝”,可治“两脚疼痹风弱”。 8、治疗神经衰弱:秋天里很多中老年人会出现体倦乏力的情况,有些人患上了神经衰弱,失眠多梦而且记忆力差。哈尔滨医科大学附属第四医院中医专家陈建国指出,中老年人在秋天不妨服用些刺五加,对治疗神经衰弱很有好处。
藕:味甘,性凉,主补中焦,养神,益气力。能清热生津,凉血止血,散瘀血。熟用微温,能补益脾胃,止泻,益血,生肌。补中养神,除百病。常服,轻身耐老,延年益寿。补益十二经脉血气,平体内阳热过盛、火旺。交心肾,厚肠胃,固精气,强筋骨,补虚损,利耳目,并除寒湿,止脾泄久痢,女子非经期出血过多等症。生食过多,微动气。捣碎和米煮粥饭食,使人强健,蒸食也好。大便燥涩的人不能吃之。莲是益脾之果。
山茱萸:补益肝肾;收敛固脱。主治头晕目眩;耳聋耳鸣;腰膝酸软;遗精滑精;小便频数;山茱萸虚汗不止;妇女崩漏;内热消渴;温肝补肾,除一切风,止月经过多,治老人尿频。
薏苡仁:薏苡仁,中药,别名 米仁、六谷、川谷、菩提子。为禾本科植物薏苡Coix lacryma-jobi L. var. meyuan (Romen.) Stapf的种仁。有健脾渗湿,除痹止泻。用于水肿、脚气、小便不利、湿痹拘挛、脾虚泄泻的功效。
猪苓:经济价值:子实体幼嫩时可食用,味道十分鲜美。其地下菌核黑色、形状多样,是著名中药,有利尿治水肿之功效。含猪苓多糖(glucan),试验抗癌。
人参:功效:大补元气,复脉固脱,补脾益肺,生津,安神。主治:体虚欲脱,肢冷脉微,脾虚食少,肺虚喘咳,津伤口渴,内热消渴,久病虚羸,惊悸失眠,阳痿宫冷;心力衰竭,心原性休克。用于气短喘促,心悸健忘,口渴多汗,食少无力,一切急慢性疾病及失血后引起的休克、虚脱。大补元气,固脱生津,安神。治劳伤虚损,食少,倦怠,反胃吐食,大便滑泄,虚咳喘促,自汗暴脱,惊悸,健忘,眩晕头痛,阳痿,尿频,消渴,妇女崩漏,小儿慢惊,及久虚不复,一切气血津液不足之证。
车前子:喜温暖湿润气候,耐寒,山区平地均可生长,对土壤要求不严。本品性味甘寒,入肾、膀胱、肝、肺经,功能利水通淋、渗湿止泻、清肝明目、清热化痰,为常用药材。
地胆头:全草入药,有清热解毒、消肿利尿之功效,治感冒、菌痢、胃肠炎、扁桃体炎、咽喉炎、肾炎水肿、结膜炎、疖肿等症,为中医常用药。
黄芪:黄芪有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。能消除实验性肾炎蛋白尿,增强心肌收缩力,调节血糖含量。黄芪不仅能扩张冠状动脉,改善心肌供血,提高免疫功能,而且能够延缓细胞衰老的进程。
茯苓:味甘、淡,性平。归 经归心、肺、脾、肾经。功效利水渗湿,健脾,宁心。
主治用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。
肉桂:味辛、甘,性大热。归经归肾、脾、心、肝经。功能有补火助阳,引火归元,散寒止痛,温通经脉的功效。主治用于阳痿宫冷,腰膝冷痛,肾虚作喘,虚阳上浮,眩晕目赤,心腹冷痛,虚寒吐泻,寒疝腹痛,痛经经闭。
茜草:凉血活血,祛瘀,通经。用于吐血、衄血、崩漏下血、外伤出血、经闭瘀阻、关节痹痛、跌扑肿痛。凉血止血,活血祛瘀:本品止血而不留瘀,用于热证出血、经闭腹痛、跌打损伤。
豇豆:基原:为豆科豇豆属植物豇豆的种子。成分:含氨基酸:胱氨酸,天冬氨酸,苏氨酸,丝氨酸,谷氨酸,甘氨酸,丙氨酸,甲硫氨酸等。药性:甘、咸,平。归脾、肾经。功用主治:健脾利湿,补肾涩精。主治脾胃虚弱,吐泻痢疾,肾虚腰痛,遗精,消渴,白带白浊,小便频数。
菟丝子:基原:为旋花科菟丝子属植物菟丝子的全草。成分:菟丝子含生物碱、蒽醌、香豆素、黄酮、甙类、甾醇、鞣酸、糖类等。黄酮类有:槲皮素、紫云英甙、金丝桃甙;甾醇类有:胆甾醇、菜油甾醇、β-谷甾醇、豆甾醇、β-香树脂醇。 亦含微量元素如锶、钼、钙、镁、铁、锰、锌、铜等以及多种氨基酸(种子中的游离氨基酸和水解后的总氨基酸为5.3%,其中必需氨基酸的含量占42.8%)。药性:微辛,甘,平,无毒。功用主治:补肾益精,养肝明目。适用于肝肾不足的腰膝筋骨酸痛,腿脚软弱无力、阳痿遗精、呓语、小便频数、尿有余沥、头晕眼花、视物不清、耳鸣耳聋以及妇女带下、习惯性流产等症。
草苁蓉:基原:位列当科草苁蓉属植物草苁蓉的全草。成分:全草含糖苷类:草苁蓉苯丙烯醇苷A、B、C、D,草苁蓉苷,草苁蓉醛苷。环烯醚萜苷类,酸类:8-表去氧马钱子甘酸,没食子酸,桂皮酸,咖啡酸,对香豆酸,等。地上部分含有苁蓉醛碱,和草苁蓉内酯。药性:甘、咸、温。功用主治:补肾壮阳,润肠通便,止血。主治肾虚阳痿,遗精,腰膝冷痛,小便遗沥,尿血,宫冷不孕,崩漏,带下,肠燥便秘。《现代植物药:“为强壮补精药。治遗精,阳痿,暖腰膝,催情欲。对与膀胱炎、膀胱出血及肾脏出血时为止血药用。”“滋润五脏,益髓,强筋,治五劳七伤,绝阳不兴,绝阴不产,腰膝冷痛,遗精带下。
本发明健脾补肾丸剂基于中医中药缓解尿毒症的原理。选用的药材均有健脾补肾、利尿的功效,针对尿毒症症状,从根源处入手,属于标本兼治的组方。对尿毒症有极好的治疗作用。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不被此限制。
实施例1缓解尿毒症的健脾补肾丸剂,取下述重量配比的主要原料制备而成(每份取10g):积雪草1份, 刺五加2份,藕4份,山茱萸3份,薏苡仁2份,猪苓1份,人参6份,车前子1份,地胆头10份,茯苓5份,肉桂4份,茜草10份,豇豆7份,菟丝子6份,黄芪8份,草苁蓉5份。
上述缓解尿毒症的健脾补肾丸剂,制备步骤如下:
①将草苁蓉和猪苓洗净,置于阴凉通风处晾干,捣碎后放入瓦罐中,加入黄酒,稍焖1小时,得酒草苁蓉和猪苓,将麸皮置于干锅内,将麸皮炒制滑利状态,投入酒草苁蓉和猪苓,反复翻炒3分钟,停火,筛去麸皮,将炒制好的草苁蓉和猪苓晾凉研磨成细末过80目筛待用;
②将藕去皮,与豇豆一同洗净,切成豆粒大小的块,置于蒸笼上,加热10分钟,稍焖10分钟取出,铺设在干净的铁板上小火慢烘5分钟,取出晾凉至室温,研磨成细末待用;
③将积雪草、 刺五加、地胆头、人参和茜草洗净,打碎,将热锅烧干,投入处理好的原料药,反复翻炒2分钟,晾至室温,研磨成细末待用;
④将山茱萸、薏苡仁、车前子、茯苓、肉桂、菟丝子和黄芪用50℃的水浸泡50分钟,置于砂锅内加水煎煮20分钟,用水量为原料药总重量的2倍,过滤得滤液;
⑤将步骤①-③所得细末与步骤④所得滤液混匀,充分搅拌5分钟后加入蜂蜜,快速搅拌成稠膏,将稠膏烘10分钟,得烘干物,将烘干物按照丸剂的加工制备方法制成圆形,包装即得。
典型病例一:赫XX,男,45岁,北京人士。2012年秋天患者来诊,患者自述:患者自述最近总是感觉全身无力,不愿意动,腰疼的直不起来,也不思饮食,即使勉强吃点,也会很难消化,晚上都不敢多喝水,已有1年多的时间。一年以来去医院检查过好多次,吃过很多中西药均无明显效果,在医生的建议下开始服用本发明健脾补肾丸剂。
服用本实施例1所得健脾补肾丸剂,每日三次,于三餐后半小时服用,每次取1片,用温开水送服。服用7天,腰酸腰疼的症状减轻;服用1个月,全身有力气了,晚上也不起夜了,继续服用2个月,不适症状完全消失,患者自感身体强健。
实施例2缓解尿毒症的健脾补肾丸剂,取下述重量配比的主要原料制备而成(每份取10g):积雪草5份, 刺五加6份,藕10份,山茱萸8份,薏苡仁4份,猪苓3份,人参10份,车前子5份,地胆头20份,茯苓15份,肉桂10份,茜草20份,豇豆18份,菟丝子14份,黄芪19份,草苁蓉7份。
上述缓解尿毒症的健脾补肾丸剂,制备步骤如下:
①将草苁蓉和猪苓洗净,置于阴凉通风处晾干,捣碎后放入瓦罐中,加入黄酒,稍焖3小时,得酒草苁蓉和猪苓,将麸皮置于干锅内,将麸皮炒制滑利状态,投入酒草苁蓉和猪苓,反复翻炒8分钟,停火,筛去麸皮,将炒制好的草苁蓉和猪苓晾凉研磨成细末过120目筛待用;
②将藕去皮,与豇豆一同洗净,切成豆粒大小的块,置于蒸笼上,加热20分钟,稍焖10分钟取出,铺设在干净的铁板上小火慢烘10分钟,取出晾凉至室温,研磨成细末待用;
③将积雪草、 刺五加、地胆头、人参和茜草洗净,打碎,将热锅烧干,投入处理好的原料药,反复翻炒6分钟,晾至室温,研磨成细末待用;
④将山茱萸、薏苡仁、车前子、茯苓、肉桂、菟丝子和黄芪用70℃的水浸泡70分钟,置于砂锅内加水煎煮50分钟,用水量为原料药总重量的4倍,过滤得滤液;
⑤将步骤①-③所得细末与步骤④所得滤液混匀,充分搅拌10分钟后加入蜂蜜,快速搅拌成稠膏,将稠膏烘30分钟,得烘干物,将烘干物按照丸剂的加工制备方法制成圆形,包装即得。
实施例3缓解尿毒症的健脾补肾丸剂,取下述重量配比的主要原料制备而成(每份取10g):积雪草2份, 刺五加3份,藕6份,山茱萸5份,薏苡仁2.5份,猪苓1.5份,人参7份,车前子2份,地胆头13份,茯苓8份,肉桂6份,茜草13份,豇豆10份,菟丝子8份,黄芪12份,草苁蓉5.5份。
上述缓解尿毒症的健脾补肾丸剂,制备步骤如下:
①将草苁蓉和猪苓洗净,置于阴凉通风处晾干,捣碎后放入瓦罐中,加入黄酒,稍焖1.5小时,得酒草苁蓉和猪苓,将麸皮置于干锅内,将麸皮炒制滑利状态,投入酒草苁蓉和猪苓,反复翻炒5分钟,停火,筛去麸皮,将炒制好的草苁蓉和猪苓晾凉研磨成细末过90目筛待用;
②将藕去皮,与豇豆一同洗净,切成豆粒大小的块,置于蒸笼上,加热13分钟,稍焖10分钟取出,铺设在干净的铁板上小火慢烘6分钟,取出晾凉至室温,研磨成细末待用;
③将积雪草、 刺五加、地胆头、人参和茜草洗净,打碎,将热锅烧干,投入处理好的原料药,反复翻炒3分钟,晾至室温,研磨成细末待用;
④将山茱萸、薏苡仁、车前子、茯苓、肉桂、菟丝子和黄芪用55℃的水浸泡55分钟,置于砂锅内加水煎煮30分钟,用水量为原料药总重量的2.5倍,过滤得滤液;
⑤将步骤①-③所得细末与步骤④所得滤液混匀,充分搅拌6分钟后加入蜂蜜,快速搅拌成稠膏,将稠膏烘15分钟,得烘干物,将烘干物按照丸剂的加工制备方法制成圆形,包装即得。
典型病例二:邹XX,男,60岁,山东省青岛市城阳区。一直从事会计工作,症状:患者自述半年前出现精神状态不佳,晚上老是失眠,工作没精神等症状,不仅如此患者最近半年还出现了闭经的现象,起初以为是到了闭经的年龄,来诊时间:2013年1月12日,由于患者不喜欢用药物治疗,所以医生建议服用本发明健脾补肾丸剂。
服用本实施例3所得健脾补肾丸剂,每日三次,于三餐后半小时服用,每次取2片,用温开水送服。服用10天,精神状态良好,睡眠质量提高;服用1个月,月经恢复正常;继续服用2个月,不适症状完全消失。
实施例4缓解尿毒症的健脾补肾丸剂,取下述重量配比的主要原料制备而成(每份取10g):积雪草4份, 刺五加5份,藕8份,山茱萸7份,薏苡仁3.5份,猪苓2.5份,人参9份,车前子4份,地胆头18份,茯苓13份,肉桂8份,茜草18份,豇豆15份,菟丝子12份,黄芪17份,草苁蓉6.5份。
上述缓解尿毒症的健脾补肾丸剂,制备步骤如下:
①将草苁蓉和猪苓洗净,置于阴凉通风处晾干,捣碎后放入瓦罐中,加入黄酒,稍焖2.5小时,得酒草苁蓉和猪苓,将麸皮置于干锅内,将麸皮炒制滑利状态,投入酒草苁蓉和猪苓,反复翻炒7分钟,停火,筛去麸皮,将炒制好的草苁蓉和猪苓晾凉研磨成细末过110目筛待用;
②将藕去皮,与豇豆一同洗净,切成豆粒大小的块,置于蒸笼上,加热18分钟,稍焖10分钟取出,铺设在干净的铁板上小火慢烘9分钟,取出晾凉至室温,研磨成细末待用;
③将积雪草、 刺五加、地胆头、人参和茜草洗净,打碎,将热锅烧干,投入处理好的原料药,反复翻炒5分钟,晾至室温,研磨成细末待用;
④将山茱萸、薏苡仁、车前子、茯苓、肉桂、菟丝子和黄芪用65℃的水浸泡65分钟,置于砂锅内加水煎煮40分钟,用水量为原料药总重量的3.5倍,过滤得滤液;
⑤将步骤①-③所得细末与步骤④所得滤液混匀,充分搅拌9分钟后加入蜂蜜,快速搅拌成稠膏,将稠膏烘25分钟,得烘干物,将烘干物按照丸剂的加工制备方法制成圆形,包装即得。
典型病例三:杨XX,女,38岁,山东省济南市人。长期干农活,2012年12月来诊,患者自述两年来不明原因的间歇性腰膝酸软,而且消化不良,偶有返酸、烧灼感、嗳气等上消化道症状,吃过许多治疗腰膝酸软的药物,当时有效,但治标不治本,不能根治,现在消瘦明显,体重下降,医生建议服用本发明健脾补肾丸剂。
服用实施例4所得健脾补肾丸剂,每日三次,于三餐后半小时服用,每次取3片,用温开水送服。服用15天,消化不良、腰膝酸软等症状减轻;服用45天,消化正常;继续服用2个月,不适症状完全消失,体重亦恢复正常。
实施例5缓解尿毒症的健脾补肾丸剂,取下述重量配比的主要原料制备而成(每份取10g):积雪草3份, 刺五加4份,藕7份,山茱萸6份,薏苡仁3份,猪苓2份,人参8份,车前子3份,地胆头15份,茯苓10份,肉桂7份,茜草15份,豇豆12份,菟丝子10份,黄芪14份,草苁蓉6份。
上述缓解尿毒症的健脾补肾丸剂,制备步骤如下:
①将草苁蓉和猪苓洗净,置于阴凉通风处晾干,捣碎后放入瓦罐中,加入黄酒,稍焖2小时,得酒草苁蓉和猪苓,将麸皮置于干锅内,将麸皮炒制滑利状态,投入酒草苁蓉和猪苓,反复翻炒6分钟,停火,筛去麸皮,将炒制好的草苁蓉和猪苓晾凉研磨成细末过100目筛待用;
②将藕去皮,与豇豆一同洗净,切成豆粒大小的块,置于蒸笼上,加热15分钟,稍焖10分钟取出,铺设在干净的铁板上小火慢烘8分钟,取出晾凉至室温,研磨成细末待用;
③将积雪草、 刺五加、地胆头、人参和茜草洗净,打碎,将热锅烧干,投入处理好的原料药,反复翻炒4分钟,晾至室温,研磨成细末待用;
④将山茱萸、薏苡仁、车前子、茯苓、肉桂、菟丝子和黄芪用60℃的水浸泡60分钟,置于砂锅内加水煎煮35分钟,用水量为原料药总重量的3倍,过滤得滤液;
⑤将步骤①-③所得细末与步骤④所得滤液混匀,充分搅拌8分钟后加入蜂蜜,快速搅拌成稠膏,将稠膏烘20分钟,得烘干物,将烘干物按照丸剂的加工制备方法制成圆形,包装即得。
实验例:为了验证本发明中药健脾补肾丸剂(实施例5)的效果,我们抽取了400名患者进行了药物的实验,平均分为二组,实验组及对照组,实验组服用本发明所得健脾补肾丸剂,对照组服用其它治疗缓解尿毒症的药物。入选标准:有尿毒症症状的一项或多项。疗效情况判定标准:1、治愈。服用药物后,不适症状完全消失;2、有效。服用药物后,不适症状减轻或部分消失;3、无效。服用药物后,不适症状无变化。
我们对实验数据进行了精确的统计和数理分析。具体实验结果如下表:
本发明健脾补肾丸剂与其它缓解尿毒症的药物相比治愈率高,总有效率为98%,比对照组有效率高33%,效果明显优于对照组,该发明健脾补肾丸剂造价低廉,普通百姓长期使用,也不会增加身体和金钱上的负担。临床实验中未出现一例副作用情况,安全性远高于其它缓解尿毒症的药物,且见效快,治疗过程无痛苦,是目前缓解尿毒症最为快速有效的中药药物。
Claims (10)
1.一种缓解尿毒症的健脾补肾丸剂,其特征在于:取下述重量配比的主要原料制备而成:积雪草1-5份, 刺五加2-6份,藕4-10份,山茱萸3-8份,薏苡仁2-4份,猪苓1-3份,人参6-10份,车前子1-5份,地胆头10-20份,茯苓5-15份,肉桂4-10份,茜草10-20份,豇豆7-18份,菟丝子6-14份,黄芪8-19份,草苁蓉5-7份。
2.根据权利要求1所述的缓解尿毒症的健脾补肾丸剂,其特征在于:取下述重量配比的主要原料制备而成:积雪草2-4份, 刺五加3-5份,藕6-8份,山茱萸5-7份,薏苡仁2.5-3.5份,猪苓1.5-2.5份,人参7-9份,车前子2-4份,地胆头13-18份,茯苓8-13份,肉桂6-8份,茜草13-18份,豇豆10-15份,菟丝子8-12份,黄芪12-17份,草苁蓉5.5-6.5份。
3.根据权利要求1所述的缓解尿毒症的健脾补肾丸剂,其特征在于:取下述重量配比的主要原料制备而成:积雪草3份, 刺五加4份,藕7份,山茱萸6份,薏苡仁3份,猪苓2份,人参8份,车前子3份,地胆头15份,茯苓10份,肉桂7份,茜草15份,豇豆12份,菟丝子10份,黄芪14份,草苁蓉6份。
4.根据权利要求1-3任一项所述的缓解尿毒症健脾补肾丸剂的制备方法,其特征在于:步骤如下:
①将草苁蓉和猪苓洗净,置于阴凉通风处晾干,捣碎后放入瓦罐中,加入黄酒,稍焖1-3小时,得酒草苁蓉和猪苓,将麸皮置于干锅内,将麸皮炒制滑利状态,投入酒草苁蓉和猪苓,反复翻炒3-8分钟,停火,筛去麸皮,将炒制好的草苁蓉和猪苓晾凉研磨成细末过80-120目筛待用;
②将藕去皮,与豇豆一同洗净,切成豆粒大小的块,置于蒸笼上,加热10-20分钟,稍焖10分钟取出,铺设在干净的铁板上小火慢烘5-10分钟,取出晾凉至室温,研磨成细末待用;
③将积雪草、 刺五加、地胆头、人参和茜草洗净,打碎,将热锅烧干,投入处理好的原料药,反复翻炒2-6分钟,晾至室温,研磨成细末待用;
④将山茱萸、薏苡仁、车前子、茯苓、肉桂、菟丝子和黄芪用50-70℃的水浸泡50-70分钟,置于砂锅内加水煎煮20-50分钟,用水量为原料药总重量的2-4倍,过滤得滤液;
⑤将步骤①-③所得细末与步骤④所得滤液混匀,充分搅拌5-10分钟后加入蜂蜜,快速搅拌成稠膏,将稠膏烘10-30分钟,得烘干物,将烘干物按照丸剂的加工制备方法制成圆形,包装即得。
5.根据权利要求4所述的健脾补肾丸剂的制备方法,其特征在于:步骤①加入黄酒,稍焖1.5-2.5小时(优选加入黄酒,稍焖2小时)。
6.根据权利要求4所述的健脾补肾丸剂的制备方法,其特征在于:步骤①投入酒草苁蓉和猪苓,反复翻炒5-7分钟(优选投入酒草苁蓉和猪苓,反复翻炒6分钟)。
7.根据权利要求4所述的健脾补肾丸剂的制备方法,其特征在于:步骤②置于蒸笼上,加热13-18分钟,稍焖10分钟取出,铺设在干净的铁板上小火慢烘6-9分钟(优选置于蒸笼上,加热15分钟,稍焖10分钟取出,铺设在干净的铁板上小火慢烘7分钟)。
8.根据权利要求4所述的健脾补肾丸剂的制备方法,其特征在于:步骤③投入处理好的原料药,反复翻炒3-5分钟,晾至室温(优选投入处理好的原料药,反复翻炒4分钟,晾至室温)。
9.根据权利要求4所述的健脾补肾丸剂的制备方法,其特征在于:步骤④将山茱萸、薏苡仁、车前子、茯苓、肉桂、菟丝子和黄芪用55-65℃的水浸泡55-65分钟,置于砂锅内加水煎煮30-40分钟,用水量为原料药总重量的2.5-3.5倍(优选将山茱萸、薏苡仁、车前子、茯苓、肉桂、菟丝子和黄芪用60℃的水浸泡60分钟,置于砂锅内加水煎煮35分钟,用水量为原料药总重量的3倍)。
10.根据权利要求4所述的健脾补肾丸剂的制备方法,其特征在于:步骤⑤充分搅拌6-9分钟后加入蜂蜜,快速搅拌成稠膏,将稠膏烘15-25分钟(优选充分搅拌8分钟后加入蜂蜜,快速搅拌成稠膏,将稠膏烘20分钟)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510317179.8A CN104940719A (zh) | 2015-06-11 | 2015-06-11 | 一种缓解尿毒症的健脾补肾丸剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510317179.8A CN104940719A (zh) | 2015-06-11 | 2015-06-11 | 一种缓解尿毒症的健脾补肾丸剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104940719A true CN104940719A (zh) | 2015-09-30 |
Family
ID=54156142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510317179.8A Pending CN104940719A (zh) | 2015-06-11 | 2015-06-11 | 一种缓解尿毒症的健脾补肾丸剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104940719A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109907145A (zh) * | 2019-04-24 | 2019-06-21 | 湖南省定生保健品经营有限公司 | 茶疗饮品的制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1207907A (zh) * | 1997-08-08 | 1999-02-17 | 王建国 | 肾炎口服液 |
CN1304755A (zh) * | 2000-12-01 | 2001-07-25 | 张志祥 | 补肾丸及其制备方法 |
CN101204517A (zh) * | 2007-12-13 | 2008-06-25 | 张映明 | 用于治疗肾病的中药 |
-
2015
- 2015-06-11 CN CN201510317179.8A patent/CN104940719A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1207907A (zh) * | 1997-08-08 | 1999-02-17 | 王建国 | 肾炎口服液 |
CN1304755A (zh) * | 2000-12-01 | 2001-07-25 | 张志祥 | 补肾丸及其制备方法 |
CN101204517A (zh) * | 2007-12-13 | 2008-06-25 | 张映明 | 用于治疗肾病的中药 |
Non-Patent Citations (1)
Title |
---|
韩秀芬: "益肾降浊化瘀法为主治疗慢性肾衰竭38例", 《实用中医内科杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109907145A (zh) * | 2019-04-24 | 2019-06-21 | 湖南省定生保健品经营有限公司 | 茶疗饮品的制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104367879A (zh) | 一种用于治疗鸡劳伤的药物组合物及其制备方法 | |
CN103689559A (zh) | 一种有助于改善胃肠功能的养生保健食品配方及其制备方法 | |
CN104740437A (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
CN104873877A (zh) | 一种降低血糖、调理体质的中药组合物 | |
CN104225532B (zh) | 治疗强直性脊柱炎的健脾温肾丸 | |
CN106540167A (zh) | 一种减肥中药 | |
CN105381424A (zh) | 一种用于人体脏腑排毒的中药剂及制备方法 | |
CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
CN104906507A (zh) | 一种降低血压、调理体质的中药组合物 | |
CN104940720A (zh) | 一种防治造影剂肾病的中药丸剂及其制备方法 | |
CN106362120A (zh) | 一种治疗高血糖和糖尿病的中药方剂 | |
CN104645123A (zh) | 一种防治慢性肾功能衰竭的丸剂及制备方法 | |
CN104940719A (zh) | 一种缓解尿毒症的健脾补肾丸剂及其制备方法 | |
CN105106916A (zh) | 一种产后护理用中药 | |
CN105456739A (zh) | 一种金钗石斛虫茶酒 | |
CN104840828A (zh) | 一种改善慢性肾功能不全的组合物及其制备方法 | |
CN104623374A (zh) | 一种治疗急性放射病的中药制剂及其制备方法 | |
CN104857372A (zh) | 一种治疗ⅱ型糖尿病合并高血压的饮品及其制备方法 | |
CN104645063A (zh) | 一种治疗乳腺增生的丸剂及制备方法 | |
CN110025760A (zh) | 一种治未病的中药组合物及其制备方法 | |
CN104873841A (zh) | 一种防治慢性肾功能衰竭的健脾补肾丸剂及其制备方法 | |
CN105233093A (zh) | 一种治疗胃下垂的中药片剂 | |
CN105381333A (zh) | 一种治疗脾肾阳虚的中药组合物 | |
CN105250903A (zh) | 一种治疗四肢麻木的中药理疗水及其制备方法 | |
CN105833091A (zh) | 一种治疗糖尿病的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150930 |